Every 33 seconds a child under 13 is involved in a car crash in the United States, according to 2014 data from the U.S. Department of Transportation’s National Highway Traffic Safety Administration (NHTSA). Safety seats, if used correctly, can dramatically reduce the risk of fatality or injury. But 59 percent of car seats are misused in a way that could reduce their effectiveness, and over one-third of children killed in car crashes were completely unrestrained at the time of the crash. Today, NHTSA and the Ad Council unveiled a new series of public service advertisements (PSAs) to educate parents and caregivers about the importance of selecting the right seat for their child’s age and size, and to remind them that car seats, booster seats and seat belts offer the best protection for children in crashes and help save lives.
“Life can change in an instant. We want parents and caregivers to prepare for the unexpected, rather than face their worst nightmare,” said Dr. Mark Rosekind, NHTSA administrator. “Buckling up a child correctly and in the right seat is the best protection any parent can do to see their child walk away unharmed from a car crash.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7774451-ad-council-find-the-right-seat/
Huawei, a leading global information and communications technology (ICT) solution provider, unveiled its FusionCube for SAP HANA solution for Sinopec at the CeBIT 2015 today.
Sinopec is one of the world's largest integrated energy and chemical Groups, ranking No.3 in Fortune Global 500 in 2014. With continuous expansion of Sinopec's services, the financial report system data rapidly increases. “With the increasing applications in these years, our user base and service plane grow continuously and more and more data needs to be processed. In the era of Big Data, efficiency data processing and analysis was high on the agenda." said Li Jianfeng, Deputy Director of the Information Management Department of Sinopec, "We decided to use SAP Enterprise Data Warehouse (EDW) HANA after comparison. But this technology cannot work without a hardware platform. Finally, we chose Huawei as our long-term partner to test and optimize the platform."
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7479051-huawei-joined-hands-with-SAP/
The Häagen-Dazs® brand announced today the introduction of the Häagen-Dazs Concerto Timer app, the first iOS mobile app to integrate detailed 3D Kinect technology and video data that delivers a cutting edge augmented reality experience especially for ice cream enthusiasts.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62528-haagen-dazs-mobile-concerto-timer-app-classical-music-preparing-ice-cream
In this new video from EisnerAmper, one of the nation’s leading providers of employee retirement plan audits, partner Kriste DeAngelo presents a basic outline for how Benefit Plan Administrators should take extra care to avoid late filing of Employee Retirement Plan contributions, or remittances. View EisnerAmper’s newest video at http://www.multivu.com/players/English/7461932-eisneramperemployee-benefits/ DeAngelo, who is the lead engagement partner for over 50 retirement plan clients, says there are three steps all plan professionals should take at the outset
Determine the earliest date that your company can reasonably segregate participant deferrals from the general assets of the company and remit into the Plan, and document the company’s remittance process. 2. Follow what has been documented. 3. Check the remittance data throughout the year – this is crucial. According to DeAngelo, “Anything outside of the expected time frame could be considered a late remittance by the DOL and should be voluntarily corrected.” DeAngelo goes on to say that many benefit managers stumble on the perception that, according to the DOL, retirement plan remittances must be made “no later than the 15th business day of the following month.”
To view the multimedia release visit:
http://www.multivu.com/players/English/7461932-eisneramper-employee-benefits/
Last week, Jennifer Lawrence and other celebrities had indiscrete photos stolen and distributed across the Internet. It’s speculated that their accounts were accessed by a “brute force” attack—which can only be successful if their passwords were weak.
Weak passwords are a risk for businesses, too. Verizon found that 76% of all network intrusions exploit weak or stolen passwords.
To protect critical data, every employee at every business must use strong passwords (which have no fewer than 12 characters). But with an average of 14.3 apps per business, users are likely to take shortcuts by creating passwords that are easy to memorize – and easy to crack.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7286151-intermedia-appid-single-sign-on-passwords-one-click-access/
The Dell Storage SC4020 has been awarded the title of the Most Valuable Product by ISMB. Based on its enterprise-class storage solution, SC8000, the SC4020 supports a wide range of workloads for organizations across all industries and sizes seeking a high-performing, mid-sized SAN entry point or a remote or branch office storage solution for its size and price.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7263631-dell-storage-sc4020/
Today, Fleetmatics celebrates its 10th anniversary as a leader in the global SaaS-based mobile workforce industry, saluting a decade of several major milestones. To date, the company has approximately 523,000 vehicles under subscription, over 24,000 global businesses, 27 billion miles tracked and more than 62 billion data points collected to provide key benchmarking and business intelligence insights for companies looking to better manage expenses, employee productivity and customer satisfaction.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7237751-fleetmatics-celebrates-10th-anniversary/
Results from a large retrospective data analysis published in the American Journal of Transplantation (AJT) today, showed that liver transplantation patients who were treated early with Advagraf experienced a significantly increased graft survival benefit of 8% at 3 years post-transplant compared with patients treated with the current standard of care, tacrolimus immediate release (twice daily).
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7451251-advagraf-prolonged-release-tacrolimus/
Chiasma, Inc., a U.S. privately–held biopharma company developing octreotide capsules for the orphan condition acromegaly, today announced two new studies presented at the 97th Endocrine Society (ENDO) Annual Meeting in San Diego, Calif. The studies provide additional data from Chiasma’s Phase III trial and new findings on the patient burden of current injection therapies.
“We now have data to help clinicians determine whether octreotide capsules, if approved, are likely to help their patient with acromegaly maintain response,” said Shlomo Melmed, M.D., senior vice president and dean, Cedars–Sinai Medical Center, Los Angeles and global study principal investigator. “Furthermore, the Phase III results show the safety and efficacy of octreotide capsules can be reliably determined within 12 weeks of initiating therapy.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7436451-endo-chiasma-clinical-data/
More and more work is being done using personal mobile devices and employees expect employers to keep personal information privateMobileIron on those devices, according to new research from MobileIron (NASDAQ: MOBL). The 2015 MobileIron Trust Gap Survey, released today, examines the privacy expectations workers have when using a mobile device for work. TheMobileIron online research conducted by Harris PollMobileIron on behalf of MobileIron surveyed more than 3,500 employed adults who use a mobile device for work in France, Germany, Japan, Spain, the UK, and the US (“workers”).
“Mobile workers, especially younger workers, have an expectation of privacy when using mobile devices for work. Many would leave their jobs if their employer could see personal informationMobileIron on their device,” said Ojas Rege, Vice President, Strategy, MobileIron. “In a world where smartphones contain increasing amounts of sensitive personal data, CIOs must remember that every device is a mixed-use device and must protect employee privacy as fiercely as corporate security.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7423152-mobileiron-survey-mobile-device-privacy/
CLICK HERE TO ORDER NOW: https://tinyurl.com/MY-BEST-CBD
Check out more
Best CBD Oil 2019 - CTFO 10X PURE Is The Best CBD Oil
CTFO is a brand you can trust. You may download all 3rd party lab tests and our scientific data right from our main page. Our products are FDA: GMP Certified, organic, non-GMO, and pesticide free. Our farms are USDA regulated.
While many companies fight over who has the purest and highest concentration of CBD and which is the best CBD Oil brands, CTFO is one step ahead of the pack. We dramatically improved the delivery system of getting CBD into your body and past the liver and kidneys!
Come discover why CTFO 10X Pure is the best CBD Oil for sale that delivers more of the vital cannabinoids into your body to help promote homeostasis. 10X Pure is the gold standard for helping promote a healthy endocannabinoid system. This is the system that keeps your body in balance and helps promote healing and optimized function.
The sixth annual Productive Innovation Index released by IDEA Pharma today, which ranks biopharmaceutical companies by their ability to successfully bring innovations to market, sees Johnson & Johnson top the industry for the fourth year running.
The Productive Innovation Index measures, scores and celebrates a company’s ability to deliver innovation to patients, by objectively evaluating performance data based on a rolling five year period (2010-2015), and operates on the premise: if you gave the same molecule to two different companies in early phase, which would make the best of it?
The success of the Janssen Pharmaceutical Companies of Johnson & Johnson and its consolidation of 1st place across the past four years’ rankings is driven largely by innovations in the field of oncology, immunology, neuroscience and cardiovascular/metabolism. Notable performers include Zytiga® (prostate cancer), Imbruvica® (chronic lymphocytic leukemia and mantle cell lymphoma (co-developed and co-marketed with Pharmacyclics, an AbbVie company)), Simponi®/Simponi Aria® (rheumatoid arthritis), Stelara® (psoriasis and psoriatic arthritis), Invega Sustenna® and Invega Trinza® (schizophrenia).
To view the multimedia release go to:
http://www.multivu.com/players/uk/7770851-johnson-and-johnson-tops-idea-pharma/
